Table 1. Key frailty scores . IMWG 5 .... | American Society of Hematology

Table 1.

Key frailty scores

	IMWG⁵	Revised Myeloma Comorbidity Index²²	UK Myeloma Research Alliance Myeloma Risk Profile³¹	Mayo risk score²⁴	IFM simplified frailty²⁵
No. of patients	869	NR	2372	351	1618
Frail patients, %	30	NR	35	21	49
OS in frail patients	57% at 3 y	NR	mOS 20-25 mo	mOS 28 mo	mOS 42 mo
No. of groups	3	3	3	4	2
Parameters	Age, CCI, activities of daily living, independent activities of daily living	Estimated glomerular filtration rate, pulmonary function tests, frailty, age, cytogenetics, PS	Age, Revised International Staging System, C-reactive protein, PS	Age, N-terminal probrain natriuretic peptide, ECOG	Age, CCI, ECOG
Population	CT	CT, RW	CT	RW	CT

	IMWG⁵	Revised Myeloma Comorbidity Index²²	UK Myeloma Research Alliance Myeloma Risk Profile³¹	Mayo risk score²⁴	IFM simplified frailty²⁵
No. of patients	869	NR	2372	351	1618
Frail patients, %	30	NR	35	21	49
OS in frail patients	57% at 3 y	NR	mOS 20-25 mo	mOS 28 mo	mOS 42 mo
No. of groups	3	3	3	4	2
Parameters	Age, CCI, activities of daily living, independent activities of daily living	Estimated glomerular filtration rate, pulmonary function tests, frailty, age, cytogenetics, PS	Age, Revised International Staging System, C-reactive protein, PS	Age, N-terminal probrain natriuretic peptide, ECOG	Age, CCI, ECOG
Population	CT	CT, RW	CT	RW	CT

CT, clinical trial; mOS, median overall survival; NR, not reported; RW, real world.